Evidence map›Paper›PMID 35300309›Full record

ArticleADMET & DMPK2020

ADME prediction with KNIME:

Gabriela Falcón-Cano, Christophe Molina, Miguel Ángel Cabrera-Pérez

Abstract read
In one paragraph

Article in ADMET & DMPK, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Current pharmaceutical design · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Exploring the Inhibitory Potential ofTheScientificWorldJournal · 2024
    Article
  7. Antifungal Constituents ofMolecules (Basel, Switzerland) · 2023
    Article
  8. Review
  9. In silico Study of Antiviral Activity of Polyphenol Compounds fromAdvances and applications in bioinformatics and chemistry : AABC · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gabriela Falcón-CanoUnit of Modeling and Experimental Biopharmaceutics. Centro de Bioactivos Químicos. Universidad Central "Marta Abreu" de las Villas. Santa Clara 54830, Villa Clara, Cuba.ORCID 0000-0002-5604-6089
Christophe MolinaPIKAÏROS S.A., 31650 Saint Orens de Gameville, France.ORCID 0000-0001-9477-5920
Miguel Ángel Cabrera-PérezUnit of Modeling and Experimental Biopharmaceutics. Centro de Bioactivos Químicos. Universidad Central "Marta Abreu" de las Villas. Santa Clara 54830, Villa Clara, Cuba.ORCID 0000-0001-5897-2230

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In-silico prediction of aqueous solubility plays an important role during the drug discovery and development processes. For many years, the limited performance of in-silico solubility models has been attributed to the lack of high-quality solubility data for pharmaceutical molecules. However, some studies suggest that the poor accuracy of solubility prediction is not related to the quality of the experimental data and that more precise methodologies (algorithms and/or set of descriptors) are required for predicting aqueous solubility for pharmaceutical molecules. In this study a large and diverse database was generated with aqueous solubility values collected from two public sources; two new recursive machine-learning approaches were developed for data cleaning and variable selection, and a consensus model based on regression and classification algorithms was created. The modeling protocol, which includes the curation of chemical and experimental data, was implemented in KNIME, with the aim of obtaining an automated workflow for the prediction of new databases. Finally, we compared several methods or models available in the literature with our consensus model, showing results comparable or even outperforming previous published models.

Indexed as

ADMEaqueous solubilityKNIMEmachine learningQuantitative Structure-Property Relationship (QSPR)Random Forestsupervised recursive selection

Identifiers

PMID35300309
PMCPMC8915604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.